35295181|t|ALS in Finland: Major Genetic Variants and Clinical Characteristics of Patients With and Without the C9orf72 Hexanucleotide Repeat Expansion.
35295181|a|Background and Objectives: To analyze the frequencies of major genetic variants and the clinical features in Finnish patients with amyotrophic lateral sclerosis (ALS) with or without the C9orf72 hexanucleotide repeat expansion. Methods: A cohort of patients with motor neuron disease was recruited between 1993 and 2020 at the Helsinki University Hospital and 2 second-degree outpatient clinics in Helsinki. Finnish ancestry patients with ALS fulfilled the diagnosis according to the revised El Escorial criteria and the Awaji-criteria. Two categories of familial ALS (FALS) were used. A patient was defined FALS-A if at least 1 first- or second-degree family member had ALS, and FALS-NP, if family members had additional neurologic or psychiatric endophenotypes. Results: Of the 815 patients, 25% had FALS-A and 45% FALS-NP. C9orf72 expansion (C9pos) was found in 256 (31%) of all patients, in 58% of FALS-A category, in 48% of FALS-NP category, and in 23 or 17% of sporadic cases using the FALS-A or FALS-NP definition. C9pos or SOD1 p.D91A homozygosity was found in 328 (40%) of the 815 patients. We compared demographic and clinical characteristics between C9pos and patients with unknown cause of ALS (Unk). We found that the age at onset was significantly earlier and survival markedly shorter in the C9pos vs Unk patients with ALS. The shortest survival was found in bulbar-onset male C9pos patients, whereas the longest survival was found in Unk limb-onset males. Older age at onset associated consistently with shorter survival in C9pos and Unk patients in both limb-onset and bulbar-onset groups. There were no significant differences in the frequencies of bulbar-onset and limb-onset patients in C9pos and Unk groups. ALS-frontotemporal dementia (FTD) was more common in C9pos (17%) than in Unk (4%) patients, and of all patients with ALS-FTD, 70% were C9pos. Discussion: These results provide further evidence for the short survival of C9orf72-associated ALS. A prominent role of the C9orf72 and SOD1 variants was found in the Finnish population. An unusually high frequency of C9pos was also found among patients with sporadic ALS. The enrichment of these 2 variants likely contributes to the high incidence of ALS in Finland.
35295181	0	3	ALS	Disease	MESH:D000690
35295181	71	79	Patients	Species	9606
35295181	101	108	C9orf72	Gene	203228
35295181	259	267	patients	Species	9606
35295181	273	302	amyotrophic lateral sclerosis	Disease	MESH:D000690
35295181	304	307	ALS	Disease	MESH:D000690
35295181	329	336	C9orf72	Gene	203228
35295181	391	399	patients	Species	9606
35295181	405	425	motor neuron disease	Disease	MESH:D016472
35295181	518	528	outpatient	Species	9606
35295181	567	575	patients	Species	9606
35295181	581	584	ALS	Disease	MESH:D000690
35295181	697	709	familial ALS	Disease	MESH:C531617
35295181	711	715	FALS	Disease	MESH:C531617
35295181	730	737	patient	Species	9606
35295181	750	756	FALS-A	Disease	MESH:C531617
35295181	813	816	ALS	Disease	MESH:D000690
35295181	822	829	FALS-NP	Disease	MESH:C531617
35295181	878	889	psychiatric	Disease	MESH:D001523
35295181	926	934	patients	Species	9606
35295181	944	950	FALS-A	Disease	MESH:C531617
35295181	959	966	FALS-NP	Disease	MESH:C531617
35295181	968	975	C9orf72	Gene	203228
35295181	1024	1032	patients	Species	9606
35295181	1044	1050	FALS-A	Disease	MESH:C531617
35295181	1071	1078	FALS-NP	Disease	MESH:C531617
35295181	1134	1140	FALS-A	Disease	MESH:C531617
35295181	1144	1151	FALS-NP	Disease	MESH:C531617
35295181	1173	1177	SOD1	Gene	6647
35295181	1178	1184	p.D91A	ProteinMutation	tmVar:p|SUB|D|91|A;HGVS:p.D91A;VariantGroup:0;CorrespondingGene:6647;RS#:80265967;CorrespondingSpecies:9606;CA#:124296
35295181	1232	1240	patients	Species	9606
35295181	1303	1308	C9pos	Disease	
35295181	1313	1321	patients	Species	9606
35295181	1344	1347	ALS	Disease	MESH:D000690
35295181	1349	1352	Unk	Disease	
35295181	1449	1454	C9pos	Disease	
35295181	1458	1461	Unk	Disease	
35295181	1462	1470	patients	Species	9606
35295181	1476	1479	ALS	Disease	MESH:D000690
35295181	1534	1539	C9pos	Disease	
35295181	1540	1548	patients	Species	9606
35295181	1592	1595	Unk	Disease	
35295181	1682	1687	C9pos	Disease	
35295181	1692	1695	Unk	Disease	
35295181	1696	1704	patients	Species	9606
35295181	1837	1845	patients	Species	9606
35295181	1849	1854	C9pos	Disease	
35295181	1859	1862	Unk	Disease	
35295181	1871	1874	ALS	Disease	MESH:D000690
35295181	1875	1898	frontotemporal dementia	Disease	MESH:D057180
35295181	1900	1903	FTD	Disease	OMIM:105550
35295181	1944	1947	Unk	Disease	
35295181	1953	1961	patients	Species	9606
35295181	1974	1982	patients	Species	9606
35295181	1988	1995	ALS-FTD	Disease	OMIM:105550
35295181	2006	2011	C9pos	Disease	
35295181	2090	2097	C9orf72	Gene	203228
35295181	2109	2112	ALS	Disease	MESH:D000690
35295181	2138	2145	C9orf72	Gene	203228
35295181	2150	2154	SOD1	Gene	6647
35295181	2259	2267	patients	Species	9606
35295181	2282	2285	ALS	Disease	MESH:D000690
35295181	2366	2369	ALS	Disease	MESH:D000690
35295181	Association	MESH:D000690	RS#:80265967;HGVS:p.D91A;CorrespondingGene:6647
35295181	Association	MESH:C531617	203228
35295181	Association	MESH:D057180	203228
35295181	Association	MESH:D000690	203228
35295181	Association	MESH:D000690	6647

